None of available vaccines affect fertility of either men or women: MoHFW

The Ministry of Health and Family Welfare in a press release on Wednesday stated that none of the available vaccines affects the fertility of either men or women.

Covaxin, Covishield, serum institute of india, bharat biotech, vaccine, vaccination, coronavirus, covid
ANI General News
2 min read Last Updated : Jun 30 2021 | 7:32 PM IST

Putting concerns regarding COVID-19 vaccination at rest, the Ministry of Health and Family Welfare in a press release on Wednesday stated that none of the available vaccines affects the fertility of either men or women.

"There is no scientific evidence suggesting COVID-19 vaccination can cause infertility in men and women. The vaccines have been found to be safe and effective," the ministry said.

The ministry said that all vaccines and their constituents are tested first on animals and later in humans to assess if they have any such side effects. "Vaccines are authorized for use only after their safety and efficacy is assured," it added.

Adding to the same, Dr N. K Arora, Chairperson of COVID-19 Working Group of National Technical Advisory Group on Immunization (NTAGI) said, "Misinformation was also created during the administering of Polio vaccine in India and abroad that children who are getting the vaccine may face infertility in the future."

He assured that all vaccines go through intense scientific researches and none of the vaccines has such side-effect.

The National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) has also recommended the COVID-19 vaccination for all lactating women, terming it as safe with no need to stop or pause breastfeeding before or after the vaccination, the release informed.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Jun 30 2021 | 7:32 PM IST

Next Story